• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于细胞移植治疗的细胞重编程技术的最新进展

Recent Progress in Cell Reprogramming Technology for Cell Transplantation Therapy.

作者信息

Yamashita Toru, Abe Koji

机构信息

Department of Neurology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.

出版信息

Neurol Med Chir (Tokyo). 2016;56(3):97-101. doi: 10.2176/nmc.ra.2015-0309. Epub 2016 Feb 15.

DOI:10.2176/nmc.ra.2015-0309
PMID:26876902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4791309/
Abstract

The discovery of induced pluripotent stem (iPS) cells opened the gate for reprogramming technology with which we can change the cell fate through overexpression of master transcriptional factors. Now we can prepare various kinds of neuronal cells directly induced from somatic cells. It has been reported that overexpression of a neuron-specific transcriptional factors might change the cell fate of endogenous astroglia to neuronal cells in vivo. In addition, some research groups demonstrated that chemical compound can induce chemical-induced neuronal cells, without transcriptional factors overexpression. In this review, we briefly review recent progress in the induced neuronal (iN) cells, and discuss the possibility of application for cell transplantation therapy.

摘要

诱导多能干细胞(iPS细胞)的发现为重新编程技术打开了大门,通过该技术我们可以通过过表达主要转录因子来改变细胞命运。现在我们可以直接从体细胞制备各种神经元细胞。据报道,神经元特异性转录因子的过表达可能会在体内将内源性星形胶质细胞的细胞命运改变为神经元细胞。此外,一些研究小组表明,化合物可以在不过表达转录因子的情况下诱导化学诱导的神经元细胞。在这篇综述中,我们简要回顾了诱导神经元(iN)细胞的最新进展,并讨论了其在细胞移植治疗中的应用可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b123/4791309/0f234b5a9cb7/nmc-56-97-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b123/4791309/0f234b5a9cb7/nmc-56-97-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b123/4791309/0f234b5a9cb7/nmc-56-97-g1.jpg

相似文献

1
Recent Progress in Cell Reprogramming Technology for Cell Transplantation Therapy.用于细胞移植治疗的细胞重编程技术的最新进展
Neurol Med Chir (Tokyo). 2016;56(3):97-101. doi: 10.2176/nmc.ra.2015-0309. Epub 2016 Feb 15.
2
Chemical compound-based direct reprogramming for future clinical applications.基于化学化合物的直接重编程用于未来的临床应用。
Biosci Rep. 2018 May 8;38(3). doi: 10.1042/BSR20171650. Print 2018 Jun 29.
3
[Reprogramming of somatic cells. Problems and solutions].[体细胞重编程。问题与解决方案]
Tsitologiia. 2014;56(12):869-80.
4
Direct reprogrammed neuronal cells as a novel resource for cell transplantation therapy.直接重编程的神经元细胞作为细胞移植治疗的一种新资源。
Cell Transplant. 2014;23(4-5):435-9. doi: 10.3727/096368914X678274. Epub 2014 Mar 11.
5
Reprogramming of somatic cells: iPS and iN cells.体细胞重编程:诱导多能干细胞和诱导神经细胞。
Prog Brain Res. 2017;230:53-68. doi: 10.1016/bs.pbr.2016.12.009. Epub 2017 Feb 6.
6
In Vivo Cellular Reprogramming: The Next Generation.体内细胞重编程:下一代技术
Cell. 2016 Sep 8;166(6):1386-1396. doi: 10.1016/j.cell.2016.08.055.
7
Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications.直接心脏重编程:基础生物学和临床应用中的进展和挑战。
Circ Res. 2015 Apr 10;116(8):1378-91. doi: 10.1161/CIRCRESAHA.116.305374.
8
Late passage human fibroblasts induced to pluripotency are capable of directed neuronal differentiation.晚期传代人成纤维细胞诱导为多能性后可定向分化为神经元。
Cell Transplant. 2011;20(2):193-203. doi: 10.3727/096368910X514305. Epub 2010 Aug 17.
9
Reprogramming of pericyte-derived cells of the adult human brain into induced neuronal cells.将成人脑组织来源的周细胞重编程为诱导性神经元细胞。
Cell Stem Cell. 2012 Oct 5;11(4):471-6. doi: 10.1016/j.stem.2012.07.007.
10
Advances in reprogramming-based study of neurologic disorders.基于重编程的神经疾病研究进展。
Stem Cells Dev. 2015 Jun 1;24(11):1265-83. doi: 10.1089/scd.2015.0044. Epub 2015 Apr 6.

引用本文的文献

1
Rad51 Regulates Reprogramming Efficiency through DNA Repair Pathway.Rad51通过DNA修复途径调控重编程效率。
Dev Reprod. 2016 Jun;20(2):163-9. doi: 10.12717/DR.2016.20.2.163.

本文引用的文献

1
Direct Conversion of Normal and Alzheimer's Disease Human Fibroblasts into Neuronal Cells by Small Molecules.小分子将正常和阿尔茨海默病人类成纤维细胞直接转化为神经元细胞。
Cell Stem Cell. 2015 Aug 6;17(2):204-12. doi: 10.1016/j.stem.2015.07.006.
2
Small-Molecule-Driven Direct Reprogramming of Mouse Fibroblasts into Functional Neurons.小分子诱导的小鼠成纤维细胞直接重编程为功能性神经元。
Cell Stem Cell. 2015 Aug 6;17(2):195-203. doi: 10.1016/j.stem.2015.06.003.
3
Therapeutic potential of induced neural stem cells for spinal cord injury.
诱导神经干细胞对脊髓损伤的治疗潜力。
J Biol Chem. 2014 Nov 21;289(47):32512-25. doi: 10.1074/jbc.M114.588871. Epub 2014 Oct 6.
4
Mesenchymal stem cells: potential in treatment of neurodegenerative diseases.间充质干细胞:在神经退行性疾病治疗中的潜力
Curr Stem Cell Res Ther. 2014;9(6):513-21. doi: 10.2174/1574888x09666140923101110.
5
Direct reprogrammed neuronal cells as a novel resource for cell transplantation therapy.直接重编程的神经元细胞作为细胞移植治疗的一种新资源。
Cell Transplant. 2014;23(4-5):435-9. doi: 10.3727/096368914X678274. Epub 2014 Mar 11.
6
In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer's disease model.脑损伤和阿尔茨海默病模型中反应性神经胶质细胞在体直接重编程为功能性神经元。
Cell Stem Cell. 2014 Feb 6;14(2):188-202. doi: 10.1016/j.stem.2013.12.001. Epub 2013 Dec 19.
7
Translational challenge for bone marrow stroma cell therapy after stroke.中风后骨髓基质细胞治疗的转化挑战。
Front Neurol Neurosci. 2013;32:62-8. doi: 10.1159/000346414. Epub 2013 Jul 8.
8
Generation of induced neurons via direct conversion in vivo.体内直接转化生成诱导神经元。
Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):7038-43. doi: 10.1073/pnas.1303829110. Epub 2013 Mar 25.
9
Reprogramming of pericyte-derived cells of the adult human brain into induced neuronal cells.将成人脑组织来源的周细胞重编程为诱导性神经元细胞。
Cell Stem Cell. 2012 Oct 5;11(4):471-6. doi: 10.1016/j.stem.2012.07.007.
10
Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor.将小鼠和人成纤维细胞直接重编程为具有单一因子的多能神经干细胞。
Cell Stem Cell. 2012 Jul 6;11(1):100-9. doi: 10.1016/j.stem.2012.05.018. Epub 2012 Jun 7.